InspireMD Total Assets from 2010 to 2024
NSPR Stock | USD 2.30 0.08 3.36% |
Total Assets | First Reported 2009-06-30 | Previous Quarter 47.6 M | Current Value 42 M | Quarterly Volatility 14 M |
Check InspireMD financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among InspireMD main balance sheet or income statement drivers, such as Interest Expense of 23.9 K, Selling General Administrative of 8 M or Other Operating Expenses of 16 M, as well as many exotic indicators such as Price To Sales Ratio of 10.44, Dividend Yield of 0.0 or PTB Ratio of 1.81. InspireMD financial statements analysis is a perfect complement when working with InspireMD Valuation or Volatility modules.
InspireMD | Total Assets |
Latest InspireMD's Total Assets Growth Pattern
Below is the plot of the Total Assets of InspireMD over the last few years. Total assets refers to the total amount of InspireMD assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in InspireMD books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. InspireMD's Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in InspireMD's overall financial position and show how it may be relating to other accounts over time.
View | Last Reported 47.64 M | 10 Years Trend |
|
Total Assets |
Timeline |
InspireMD Total Assets Regression Statistics
Arithmetic Mean | 19,864,410 | |
Geometric Mean | 15,917,105 | |
Coefficient Of Variation | 73.03 | |
Mean Deviation | 11,127,480 | |
Median | 16,010,000 | |
Standard Deviation | 14,506,331 | |
Sample Variance | 210.4T | |
Range | 44.2M | |
R-Value | 0.67 | |
Mean Square Error | 124.3T | |
R-Squared | 0.45 | |
Significance | 0.01 | |
Slope | 2,179,547 | |
Total Sum of Squares | 2946.1T |
InspireMD Total Assets History
Other Fundumenentals of InspireMD
InspireMD Total Assets component correlations
Click cells to compare fundamentals
About InspireMD Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include InspireMD income statement, its balance sheet, and the statement of cash flows. InspireMD investors use historical funamental indicators, such as InspireMD's Total Assets, to determine how well the company is positioned to perform in the future. Although InspireMD investors may use each financial statement separately, they are all related. The changes in InspireMD's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on InspireMD's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on InspireMD Financial Statements. Understanding these patterns can help to make the right decision on long term investment in InspireMD. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for Next Year | ||
Total Assets | 47.6 M | 50 M | |
Intangibles To Total Assets | 0.00 | 0.00 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of InspireMD Correlation against competitors. To learn how to invest in InspireMD Stock, please use our How to Invest in InspireMD guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for InspireMD Stock analysis
When running InspireMD's price analysis, check to measure InspireMD's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InspireMD is operating at the current time. Most of InspireMD's value examination focuses on studying past and present price action to predict the probability of InspireMD's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InspireMD's price. Additionally, you may evaluate how the addition of InspireMD to your portfolios can decrease your overall portfolio volatility.
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
Is InspireMD's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of InspireMD. If investors know InspireMD will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about InspireMD listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.82) | Revenue Per Share 0.256 | Quarterly Revenue Growth 0.716 | Return On Assets (0.37) | Return On Equity (0.70) |
The market value of InspireMD is measured differently than its book value, which is the value of InspireMD that is recorded on the company's balance sheet. Investors also form their own opinion of InspireMD's value that differs from its market value or its book value, called intrinsic value, which is InspireMD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because InspireMD's market value can be influenced by many factors that don't directly affect InspireMD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between InspireMD's value and its price as these two are different measures arrived at by different means. Investors typically determine if InspireMD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, InspireMD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.